SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 57.84+1.4%2:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doc Bones who wrote (2858)2/8/2001 6:32:16 PM
From: Biomaven   of 52153
 
Doc,

Is ALXN capable of doing a good press release tying their drug into the findings?

Well I imagine they are a little gun-shy right now, but I wouldn't be surprised to see some PR from them. The real key however will be once they analyze and report on the cognitive measures in their recent Phase II.

Actually ALXN showed some relative strength yesterday, as the smart local guys that get their NEJM delivered the old fashioned way (by mail) tend to get their issue on Wednesdays.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News